Saltigo build new capacity potent APIs in US

Saltigo to build new capacity for potent APIs in US

11:02 PM, 24th October 2011
Saltigo to build new capacity for potent APIs in US
Dr Andreas Stolle, Head, Pharma business line, Saltigo.


LANGENFELD, GERMANY: Saltigo GmbH, a Lanxess subsidiary, recently announced two important strategies in its custom manufacturing services.

First, the company will build new production capacities for potent active pharmaceutical ingredients (APIs) at its site in Redmond, targeting the American pharmaceutical industry. Second, it is looking to strengthen its commitment in Japan. Recently it has received accreditation of Saltigo’s Leverkusen site by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).

Potent and highly potent active pharmaceutical ingredients of categories III and IV already play a key role among the low-molecular-weight active ingredients. This trend will continue to increase in the future.

“We have decided to expand the production capabilities at our Redmond site in Washington, US, so that we can also produce and handle highly effective category III substances there,” said Dr Andreas Stolle, Head, Pharma business line, Saltigo.

The respective capacities up to the kilogramme range will become available at the beginning of 2012 and will provide Saltigo’s customers with even more products and services from a single source. The company will then also be able to produce active ingredients with an occupational exposure limit (OEL) of less than 10 microgramme per cubic metre of air.

(C) WOC News




Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Air Liquide signs new contract with Posco in South Korea

PARIS, FRANCE: Air Liquide has signed a contract with Posco E&C, the Engineering and Construction division of Posco, to design and build two large ...

Read more
BASF to build tert.-Butylamine plant in Nanjing

  NANJING/JI’NING, CHINA: BASF will build a production plant to produce tert.-Butylamine (tBA) in Nanjing, China. The facility will be who ...

Read more
ICL acquires SQM’s 50 per cent share in Nutrisi Holdings

TEL AVIV, ISRAEL: Israel Chemicals Ltd (ICL) has agreed with SQM, a Chilean company with whom ICL currently owns Nutrisi Holdings, to purchase SQM&r ...

Read more
Researchers block morphine’s itchy side effect

  ST LOUIS, US: Itching is one of the most prevalent side effects of powerful, pain-killing drugs like morphine, oxycodone and other opioids. Th ...

Read more
DuPont asserts patent infringement claims against Monsanto

  DES MOINES, US: DuPont filed a lawsuit against Monsanto for violating a US patent protecting a novel seed production technique. The lawsuit wa ...

Read more
LyondellBasell enhances logistics service capability with distributors

ROTTERDAM, THE NETHERLANDS: LyondellBasell has developed an enhanced logistics concept with its distributors designed to improve service to its poly ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X